A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Odette Cancer Centre
Toronto, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Royal Victoria Hospital
Montreal, Quebec, Canada
- St. Mary'S Hospital Center
Montreal, Quebec, Canada
- University of Montreal Hospital Group
Montreal, Quebec, Canada
- Centre Hospitalier Affilie Universitaire de Quebec, Hospital Du St-Sacrement
Québec, Quebec, Canada
- Mbccop, San Juan, Puerto Rico
San Juan, Puerto Rico
- Mbccop, Gulf Coast
Mobile, Alabama, United States
- Scripps Cancer Center-San Diego
La Jolla, California, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- University of California, Irvine Medical Center
Long Beach, California, United States
- St. Joseph Hospital
Orange, California, United States
- Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Sutter Medical Center
Sacramento, California, United States
- Kaiser Permanente-San Diego
San Diego, California, United States
- Santa Rosa Memorial Hospital
Santa Rosa, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Memorial Hospital
Colorado Springs, Colorado, United States
- Ccop-Colorado Cancer Research Prog. Inc.(administrative Only)
Denver, Colorado, United States
- Kaiser Permanente-Franklin
Denver, Colorado, United States
- Kaiser Permanente Rock Creek
Lafayette, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Eastern Connecticut Hematology & Oncology Associates
Norwich, Connecticut, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Md Anderson Cancer Center
Orlando, Florida, United States
- Phoebe Putney Memorial Hospital
Albany, Georgia, United States
- Mbccop, Medical College of Georgia Research Institute
Augusta, Georgia, United States
- Kaiser Permanente Hawaii - Moanalua Med Center
Honolulu, Hawaii, United States
- University of Hawaii
Honolulu, Hawaii, United States
- Kootenai Cancer Center
Coeur d'Alene, Idaho, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Cancer Institute at Alexian Brothers Hospital Network
Elk Grove, Illinois, United States
- Edward Hospital
Naperville, Illinois, United States
- Edward Cancer Center Plainfield
Plainfield, Illinois, United States
- Ccop, Central Illinois
Springfield, Illinois, United States
- Ccop, Carle Cancer Center
Urbana, Illinois, United States
- St. Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 30 Jun 2012
- Completion
- 31 Mar 2017
- Last update posted
- 6 Jun 2016
- Registered enrollment
- 529
- Registry id
- NCT00486668
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.